Panel Supportive of Pfizer, Eyetech Eye Drug
151431
An experimental drug developed by Eyetech Pharmaceuticals Inc. and Pfizer Inc. for preserving vision in the elderly received a generally positive review from a US advisory panel on Friday.
427828
Pfizer Inc.'s  board of  directors was meeting on Friday to discuss plans for picking a  successor to the company's chairman and chief executive, Hank  McKinnell, who is scheduled to retire in February 2008.
438872
By Sabine Vollmer, The News & Observer, Raleigh, N.C.  Feb. 17--Adding a treatment for pink eye to its lineup of promising medicines could cost Inspire Pharmaceuticals $32 million in upfront and milestone payments.
158108
Pfizer Inc , the world's biggest drug maker, on Wednesday reported fourth-quarter results that beat expectations, sending its shares higher in premarket trading.
422768
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis.
613863
Eyetech Pharmaceuticals Inc. (EYET.O: Quote, Profile, Research) said trading in its common stock was halted on Friday before a US advisory panel meets to review its experimental drug to stop vision loss in elderly patients.
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
142281
FDA advisory panel gives the nod to its heart drug.
53765
The N.I.H. said it would sponsor a trial comparing two drugs that have sharply different costs to treat macular degeneration.
278954
Shares of Eyetech Pharmaceuticals (EYET:Nasdaq - news - research) fell Monday even though several analysts said the company&#39;s experimental eye disease drug Macugen has a good chance of securing government approval.
407477
By Alejandro Bodipo-Memba, Detroit Free Press  Sep. 7--Pfizer Inc. will donate lab equipment valued at more than $1 million to Michigan-based start-up companies focused on life-science research.
219045
WASHINGTON - An implantable lens to correct the vision of nearsighted people won approval from the Food and Drug Administration (news - web sites) on Monday.
696598
Two new trials have shown that a drug injected into the eye can effectively treat a potentially blinding form of age-related macular degeneration (AMD).
59972
Contact lenses that release controlled doses of drugs to treat eye diseases such as glaucoma have been created by nano-engineers in Singapore.
731547
Advanced Medical Optics said it is willing to pay more than the $3.67 billion the eye care company accepted from a private equity firm.
190069
The FDA issues a health advisory for a top Pfizer drug.
424285
A federal advisory panel has backed Eli Lilly & Companyâs proposed long-acting form of its schizophrenia drug Zyprexa.